To assess the in vivo role of Tbkbp1 in regulating CD8+ T cell responses, we employed a tumor immunity model involving inoculation of B16 murine melanoma cells expressing a surrogate antigen, chicken ovalbumin (OVA), to Tbkbp1-KO and WT mice. This evidence concerns the gene CD8A and melanoma.